Progestin	B:C0033306
suppressed	O
inflammation	O
and	O
cell	O
viability	I:C1516362
of	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-α	I:C1456820
-	O
stimulated	O
endometriotic	O
stromal	O
cells	I:C0162597
.	O

Progestin	O
suppressed	O
inflammation	O
and	O
cell	B:C1516362
viability	I:C1516362
of	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-α	I:C1456820
-	O
stimulated	O
endometriotic	O
stromal	O
cells	I:C0162597
.	O

Progestin	O
suppressed	O
inflammation	O
and	O
cell	O
viability	I:C1516362
of	O
tumor	B:C1456820
necrosis	I:C1456820
factor	I:C1456820
-α	I:C1456820
-	O
stimulated	O
endometriotic	O
stromal	O
cells	I:C0162597
.	O

Progestin	O
suppressed	O
inflammation	O
and	O
cell	O
viability	I:C1516362
of	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-α	I:C1456820
-	O
stimulated	O
endometriotic	B:C0014175
stromal	O
cells	I:C0162597
.	O

Progestin	O
suppressed	O
inflammation	O
and	O
cell	O
viability	I:C1516362
of	O
tumor	O
necrosis	I:C1456820
factor	I:C1456820
-α	I:C1456820
-	O
stimulated	O
endometriotic	O
stromal	B:C0162597
cells	I:C0162597
.	O

Endometriosis	B:C0014175
is	O
an	O
estrogen	O
-	O
dependent	O
inflammatory	O
disease	I:C1290884
.	O

Endometriosis	O
is	O
an	O
estrogen	B:C0014939
-	O
dependent	O
inflammatory	O
disease	I:C1290884
.	O

Endometriosis	O
is	O
an	O
estrogen	O
-	O
dependent	O
inflammatory	B:C1290884
disease	I:C1290884
.	O

Progestins	B:C0033306
are	O
a	O
first	O
-	I:C1708063
line	I:C1708063
treatment	I:C1708063
for	O
endometriosis	O
via	O
activation	O
of	O
pituitary	O
progesterone	I:C0034833
receptors	I:C0034833
and	O
suppression	O
of	I:C1535931
systemic	I:C1535931
estrogen	I:C1535931
:	O
a	O
less	O
than	O
optimal	O
treatment	I:C0087111
.	O

Progestins	O
are	O
a	O
first	B:C1708063
-	I:C1708063
line	I:C1708063
treatment	I:C1708063
for	O
endometriosis	O
via	O
activation	O
of	O
pituitary	O
progesterone	I:C0034833
receptors	I:C0034833
and	O
suppression	O
of	I:C1535931
systemic	I:C1535931
estrogen	I:C1535931
:	O
a	O
less	O
than	O
optimal	O
treatment	I:C0087111
.	O

Progestins	O
are	O
a	O
first	O
-	I:C1708063
line	I:C1708063
treatment	I:C1708063
for	O
endometriosis	B:C0014175
via	O
activation	O
of	O
pituitary	O
progesterone	I:C0034833
receptors	I:C0034833
and	O
suppression	O
of	I:C1535931
systemic	I:C1535931
estrogen	I:C1535931
:	O
a	O
less	O
than	O
optimal	O
treatment	I:C0087111
.	O

Progestins	O
are	O
a	O
first	O
-	I:C1708063
line	I:C1708063
treatment	I:C1708063
for	O
endometriosis	O
via	O
activation	O
of	O
pituitary	B:C0034833
progesterone	I:C0034833
receptors	I:C0034833
and	O
suppression	O
of	I:C1535931
systemic	I:C1535931
estrogen	I:C1535931
:	O
a	O
less	O
than	O
optimal	O
treatment	I:C0087111
.	O

Progestins	O
are	O
a	O
first	O
-	I:C1708063
line	I:C1708063
treatment	I:C1708063
for	O
endometriosis	O
via	O
activation	O
of	O
pituitary	O
progesterone	I:C0034833
receptors	I:C0034833
and	O
suppression	B:C1535931
of	I:C1535931
systemic	I:C1535931
estrogen	I:C1535931
:	O
a	O
less	O
than	O
optimal	O
treatment	I:C0087111
.	O

Progestins	O
are	O
a	O
first	O
-	I:C1708063
line	I:C1708063
treatment	I:C1708063
for	O
endometriosis	O
via	O
activation	O
of	O
pituitary	O
progesterone	I:C0034833
receptors	I:C0034833
and	O
suppression	O
of	I:C1535931
systemic	I:C1535931
estrogen	I:C1535931
:	O
a	O
less	O
than	O
optimal	B:C0087111
treatment	I:C0087111
.	O

Increasing	O
evidence	O
is	O
beginning	O
to	O
show	O
that	O
progestins	B:C0033306
may	O
also	O
influence	O
local	O
endometriotic	O
cells	O
,	O
which	O
may	O
contribute	O
to	O
their	O
clinical	O
efficacy	O
.	O

Increasing	O
evidence	O
is	O
beginning	O
to	O
show	O
that	O
progestins	O
may	O
also	O
influence	O
local	O
endometriotic	B:C0014175
cells	O
,	O
which	O
may	O
contribute	O
to	O
their	O
clinical	O
efficacy	O
.	O

Increasing	O
evidence	O
is	O
beginning	O
to	O
show	O
that	O
progestins	O
may	O
also	O
influence	O
local	O
endometriotic	O
cells	B:C0597032
,	O
which	O
may	O
contribute	O
to	O
their	O
clinical	O
efficacy	O
.	O

Endometrial	B:C0014180
stromal	O
cells	I:C0162597
(	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
)	O
isolated	O
from	O
women	O
with	O
endometriosis	O
were	O
cultured	O
with	O
TNF	O
-α	I:C1456820
to	O
simulate	O
an	O
inflammatory	O
environment	O
.	O

Endometrial	O
stromal	B:C0162597
cells	I:C0162597
(	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
)	O
isolated	O
from	O
women	O
with	O
endometriosis	O
were	O
cultured	O
with	O
TNF	O
-α	I:C1456820
to	O
simulate	O
an	O
inflammatory	O
environment	O
.	O

Endometrial	O
stromal	O
cells	I:C0162597
(	O
Endometrial	B:C0162597
stromal	I:C0162597
cells	I:C0162597
)	O
isolated	O
from	O
women	O
with	O
endometriosis	O
were	O
cultured	O
with	O
TNF	O
-α	I:C1456820
to	O
simulate	O
an	O
inflammatory	O
environment	O
.	O

Endometrial	O
stromal	O
cells	I:C0162597
(	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
)	O
isolated	O
from	O
women	B:C0043210
with	O
endometriosis	O
were	O
cultured	O
with	O
TNF	O
-α	I:C1456820
to	O
simulate	O
an	O
inflammatory	O
environment	O
.	O

Endometrial	O
stromal	O
cells	I:C0162597
(	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
)	O
isolated	O
from	O
women	O
with	O
endometriosis	B:C0014175
were	O
cultured	O
with	O
TNF	O
-α	I:C1456820
to	O
simulate	O
an	O
inflammatory	O
environment	O
.	O

Endometrial	O
stromal	O
cells	I:C0162597
(	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
)	O
isolated	O
from	O
women	O
with	O
endometriosis	O
were	O
cultured	O
with	O
TNF	B:C1456820
-α	I:C1456820
to	O
simulate	O
an	O
inflammatory	O
environment	O
.	O

Endometrial	O
stromal	O
cells	I:C0162597
(	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
)	O
isolated	O
from	O
women	O
with	O
endometriosis	O
were	O
cultured	O
with	O
TNF	O
-α	I:C1456820
to	O
simulate	O
an	O
inflammatory	O
environment	B:C0014406
.	O

Endometrial	B:C0162597
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	B:C0033306
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	B:C0065864
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	B:C0065864
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	B:C0068980
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	B:C0068980
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	B:C0057916
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	B:C0057916
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	B:C0079189
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	B:C1158816
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	B:C1159339
secretion	I:C1159339
,	O
and	O
cell	O
viability	I:C2986858
measured	I:C2986858
.	O

Endometrial	O
stromal	I:C0162597
cells	I:C0162597
were	O
treated	O
with	O
the	O
progestins	O
,	O
medroxyprogesterone	O
acetate	I:C0065864
(	O
medroxyprogesterone	O
acetate	I:C0065864
)	O
,	O
norethisterone	O
acetate	I:C0068980
(	O
norethisterone	O
acetate	I:C0068980
)	O
,	O
or	O
dienogest	O
(	O
dienogest	O
)	O
and	O
cytokine	O
mRNA	O
production	I:C1158816
,	O
protein	O
secretion	I:C1159339
,	O
and	O
cell	B:C2986858
viability	I:C2986858
measured	I:C2986858
.	O

dienogest	B:C0057916
,	O
norethisterone	O
acetate	I:C0068980
,	O
and	O
medroxyprogesterone	O
acetate	I:C0065864
suppressed	O
the	O
secretion	O
of	I:C3155041
interleukin	I:C3155041
(	O
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C0079633
8	I:C0079633
,	O
and	O
monocyte	O
chemotactic	I:C0128897
protein	I:C0128897
(	I:C0128897
MCP	I:C0128897
)	I:C0128897
-	I:C0128897
1	I:C0128897
from	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
.	O

dienogest	O
,	O
norethisterone	B:C0068980
acetate	I:C0068980
,	O
and	O
medroxyprogesterone	O
acetate	I:C0065864
suppressed	O
the	O
secretion	O
of	I:C3155041
interleukin	I:C3155041
(	O
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C0079633
8	I:C0079633
,	O
and	O
monocyte	O
chemotactic	I:C0128897
protein	I:C0128897
(	I:C0128897
MCP	I:C0128897
)	I:C0128897
-	I:C0128897
1	I:C0128897
from	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
.	O

dienogest	O
,	O
norethisterone	O
acetate	I:C0068980
,	O
and	O
medroxyprogesterone	B:C0065864
acetate	I:C0065864
suppressed	O
the	O
secretion	O
of	I:C3155041
interleukin	I:C3155041
(	O
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C0079633
8	I:C0079633
,	O
and	O
monocyte	O
chemotactic	I:C0128897
protein	I:C0128897
(	I:C0128897
MCP	I:C0128897
)	I:C0128897
-	I:C0128897
1	I:C0128897
from	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
.	O

dienogest	O
,	O
norethisterone	O
acetate	I:C0068980
,	O
and	O
medroxyprogesterone	O
acetate	I:C0065864
suppressed	O
the	O
secretion	B:C3155041
of	I:C3155041
interleukin	I:C3155041
(	O
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C0079633
8	I:C0079633
,	O
and	O
monocyte	O
chemotactic	I:C0128897
protein	I:C0128897
(	I:C0128897
MCP	I:C0128897
)	I:C0128897
-	I:C0128897
1	I:C0128897
from	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
.	O

dienogest	O
,	O
norethisterone	O
acetate	I:C0068980
,	O
and	O
medroxyprogesterone	O
acetate	I:C0065864
suppressed	O
the	O
secretion	O
of	I:C3155041
interleukin	I:C3155041
(	B:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C0079633
8	I:C0079633
,	O
and	O
monocyte	O
chemotactic	I:C0128897
protein	I:C0128897
(	I:C0128897
MCP	I:C0128897
)	I:C0128897
-	I:C0128897
1	I:C0128897
from	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
.	O

dienogest	O
,	O
norethisterone	O
acetate	I:C0068980
,	O
and	O
medroxyprogesterone	O
acetate	I:C0065864
suppressed	O
the	O
secretion	O
of	I:C3155041
interleukin	I:C3155041
(	O
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	B:C0079633
-	I:C0079633
8	I:C0079633
,	O
and	O
monocyte	O
chemotactic	I:C0128897
protein	I:C0128897
(	I:C0128897
MCP	I:C0128897
)	I:C0128897
-	I:C0128897
1	I:C0128897
from	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
.	O

dienogest	O
,	O
norethisterone	O
acetate	I:C0068980
,	O
and	O
medroxyprogesterone	O
acetate	I:C0065864
suppressed	O
the	O
secretion	O
of	I:C3155041
interleukin	I:C3155041
(	O
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C0079633
8	I:C0079633
,	O
and	O
monocyte	B:C0128897
chemotactic	I:C0128897
protein	I:C0128897
(	I:C0128897
MCP	I:C0128897
)	I:C0128897
-	I:C0128897
1	I:C0128897
from	O
Endometrial	O
stromal	I:C0162597
cells	I:C0162597
.	O

dienogest	O
,	O
norethisterone	O
acetate	I:C0068980
,	O
and	O
medroxyprogesterone	O
acetate	I:C0065864
suppressed	O
the	O
secretion	O
of	I:C3155041
interleukin	I:C3155041
(	O
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C0079633
8	I:C0079633
,	O
and	O
monocyte	O
chemotactic	I:C0128897
protein	I:C0128897
(	I:C0128897
MCP	I:C0128897
)	I:C0128897
-	I:C0128897
1	I:C0128897
from	O
Endometrial	B:C0162597
stromal	I:C0162597
cells	I:C0162597
.	O

dienogest	B:C0057916
and	O
norethisterone	O
acetate	I:C0068980
only	O
reduced	O
the	O
TNF	O
-α	I:C1456820
-	O
stimulated	O
mRNA	O
production	I:C1158816
.	O

dienogest	O
and	O
norethisterone	B:C0068980
acetate	I:C0068980
only	O
reduced	O
the	O
TNF	O
-α	I:C1456820
-	O
stimulated	O
mRNA	O
production	I:C1158816
.	O

dienogest	O
and	O
norethisterone	O
acetate	I:C0068980
only	O
reduced	O
the	O
TNF	B:C1456820
-α	I:C1456820
-	O
stimulated	O
mRNA	O
production	I:C1158816
.	O

dienogest	O
and	O
norethisterone	O
acetate	I:C0068980
only	O
reduced	O
the	O
TNF	O
-α	I:C1456820
-	O
stimulated	O
mRNA	B:C1158816
production	I:C1158816
.	O

All	O
three	O
progestins	B:C0033306
suppressed	O
TNF	O
-α	I:C1456820
-	O
stimulated	O
ESC	O
proliferation	I:C0596290
.	O

All	O
three	O
progestins	O
suppressed	O
TNF	B:C1456820
-α	I:C1456820
-	O
stimulated	O
ESC	O
proliferation	I:C0596290
.	O

All	O
three	O
progestins	O
suppressed	O
TNF	O
-α	I:C1456820
-	O
stimulated	O
ESC	B:C0596290
proliferation	I:C0596290
.	O

Progestins	B:C0033306
may	O
influence	O
endometriotic	O
stromal	O
cells	I:C0162597
altering	O
the	I:C0243095
inflammatory	I:C0243095
microenvironment	I:C0243095
and	O
their	O
clinical	O
efficacy	O
.	O

Progestins	O
may	O
influence	O
endometriotic	B:C0014175
stromal	O
cells	I:C0162597
altering	O
the	I:C0243095
inflammatory	I:C0243095
microenvironment	I:C0243095
and	O
their	O
clinical	O
efficacy	O
.	O

Progestins	O
may	O
influence	O
endometriotic	O
stromal	B:C0162597
cells	I:C0162597
altering	O
the	I:C0243095
inflammatory	I:C0243095
microenvironment	I:C0243095
and	O
their	O
clinical	O
efficacy	O
.	O

Progestins	O
may	O
influence	O
endometriotic	O
stromal	O
cells	I:C0162597
altering	B:C0243095
the	I:C0243095
inflammatory	I:C0243095
microenvironment	I:C0243095
and	O
their	O
clinical	O
efficacy	O
.	O

